New topical treatments change the pattern of treatment of psoriasis: Dermatologists remain the primary providers of this care

International Journal of Dermatology

Volumn 39, Issue 1, 2000, Pages 41-44

  Feldman, Steven R ^a   Fleischer Jr , Alan B ^a   Cooper, Jennifer Z ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM LACTATE; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; COAL TAR; DITHRANOL; ETRETINATE; FLUOCINONIDE; METHOTREXATE; METHOXSALEN; PENICILLIN V POTASSIUM; PREDNISONE; TRIAMCINOLONE; ULOBETASOL PROPIONATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG POTENCY; DRUG USE; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; MEDICAL PERSONNEL; PSORIASIS;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DATA COLLECTION; DERMATOLOGIC AGENTS; DERMATOLOGY; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0034050618     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00878.x     Document Type: Article

References (17)

1. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-496.
2. Leary MR, Rapp SR, Herbst KC, et al. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol 1998; 17: 530-536.
3. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 393-400.
4. Feldman SR. Psoriasis treatment. Curr Prob Dermatol 1998; 10: 1-40.
5. Stern RS. Utilization of outpatient care for psoriasis. J Am Acad Dermatol 1996; 35: 543-545.
6. Fleischer AB Jr, Feldman SR, McConnell RC. The most common skin problems seen by family practitioners, 1990-1994. Family Med 1997; 29: 648-652.
7. Thompson TT, Feldman SR, Fleischer AB. Only 33% of visits for skin disease in the US in 1995 were to dermatologists: is decreasing the number of dermatologists the appropriate response. Dermatol Online J 1998; 4: 3.
8. National Center for Health Statistics. Public use data tape documentation. 1990 National Ambulatory Medical Survey. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1992.
9. Feldman SR, Williford PM, Fleischer AB Jr. Lower utilization of dermatologists in managed care: despite growth in managed care, visits to dermatologists did not decrease: an analysis of National Ambulatory Medical Care Survey data, 1990-1992. J Invest Dermatol 1996; 107: 860-864.
10. Stoughton RB. Vasoconstrictor assay-specific applications. In: Maibach HI, Surber C, eds. Topical Corticosteroids. Basel, Switzerland: Karger, 1992: 42-53.
11. Ruzicka T, Lorenz B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 1998; 138: 254-258.
12. Lebwohl M, Didkin SB, Epinette W, et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996; 35: 268-269.
13. Lebwohl M. Topical application of calcipotriene and corticosteroids: combination regimens. J Am Acad Dermatol 1997; 37: S55-S58.
14. Lebwohl M, Yoles A, Lombardi K, Lou W. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol 1998; 39: 447-450.
15. Patel B, Siskin S, Krazmien R, Lebwohl M. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 1998; 38: 1010-1011.
16. Koo J. How and why to use sequential therapy for psoriasis. Skin Aging 1998; 42-46.
17. Lebwohl MG, Breneman DL, Goffe BS, et al. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol 1998; 39: 590-596.